118 related articles for article (PubMed ID: 36394079)
41. Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma.
Zhang T; Cai J; Chang J; Yu D; Wu C; Yan T; Zhai K; Bi X; Zhao H; Xu J; Tan W; Qu C; Lin D
Hum Mol Genet; 2013 Mar; 22(6):1262-9. PubMed ID: 23213177
[TBL] [Abstract][Full Text] [Related]
42. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.
Jiang DK; Yao L; Ren WH; Wang WZ; Peng B; Yu L
Med Oncol; 2011 Dec; 28(4):1129-35. PubMed ID: 20552298
[TBL] [Abstract][Full Text] [Related]
43. Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.
Su CK; Yeh KT; Yeh CB; Wang PH; Ho ES; Chou MC; Liu KC; Yang SF; Yi YC
J Surg Oncol; 2011 Dec; 104(7):755-9. PubMed ID: 21761413
[TBL] [Abstract][Full Text] [Related]
44. Genetic polymorphism of the tissue inhibitor of metalloproteinase-1 is associated with an increased risk of endometrial cancer.
Yi YC; Chen MK; Chen LY; Ho ES; Ying TH; Wang PH; Yang SF
Clin Chim Acta; 2009 Nov; 409(1-2):127-31. PubMed ID: 19758569
[TBL] [Abstract][Full Text] [Related]
45. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
[TBL] [Abstract][Full Text] [Related]
46. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population.
Xu HL; Xu WH; Cai Q; Feng M; Long J; Zheng W; Xiang YB; Shu XO
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2114-22. PubMed ID: 19531679
[TBL] [Abstract][Full Text] [Related]
48. A Tumor-Promoting Phorbol Ester Causes a Large Increase in APOBEC3A Expression and a Moderate Increase in APOBEC3B Expression in a Normal Human Keratinocyte Cell Line without Increasing Genomic Uracils.
Siriwardena SU; Perera MLW; Senevirathne V; Stewart J; Bhagwat AS
Mol Cell Biol; 2019 Jan; 39(1):. PubMed ID: 30348839
[TBL] [Abstract][Full Text] [Related]
49. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
Adolph MB; Love RP; Feng Y; Chelico L
Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
[TBL] [Abstract][Full Text] [Related]
50. Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association.
Weiss JM; Weiss NS; Ulrich CM; Doherty JA; Chen C
Gynecol Oncol; 2006 Dec; 103(3):891-6. PubMed ID: 16806437
[TBL] [Abstract][Full Text] [Related]
51. A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.
Caval V; Suspène R; Shapira M; Vartanian JP; Wain-Hobson S
Nat Commun; 2014 Oct; 5():5129. PubMed ID: 25298230
[TBL] [Abstract][Full Text] [Related]
52. Involvement of APOBEC3A/B Deletion in Mouse Mammary Tumor Virus (MMTV)-like Positive Human Breast Cancer.
de Sousa Pereira N; Vitiello GAF; Amarante MK
Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980505
[TBL] [Abstract][Full Text] [Related]
53. Association of APOBEC3 deletion with cancer risk: A meta-analysis of 26 225 cases and 37 201 controls.
Hashemi M; Moazeni-Roodi A; Taheri M
Asia Pac J Clin Oncol; 2019 Dec; 15(6):275-287. PubMed ID: 30693645
[TBL] [Abstract][Full Text] [Related]
54. Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population.
Xu WH; Long JR; Zheng W; Ruan ZX; Cai Q; Cheng JR; Xiang YB; Shu XO
Cancer; 2009 Jun; 115(12):2693-700. PubMed ID: 19382201
[TBL] [Abstract][Full Text] [Related]
55. Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival.
Einarsdóttir K; Darabi H; Czene K; Li Y; Low YL; Li YQ; Bonnard C; Wedrén S; Liu ET; Hall P; Liu J; Humphreys K
Br J Cancer; 2009 Apr; 100(8):1358-64. PubMed ID: 19319135
[TBL] [Abstract][Full Text] [Related]
56. Polymorphisms in base excision repair genes are associated with endometrial cancer risk among postmenopausal Japanese women.
Hosono S; Matsuo K; Ito H; Oze I; Hirose K; Watanabe M; Nakanishi T; Tajima K; Tanaka H
Int J Gynecol Cancer; 2013 Nov; 23(9):1561-8. PubMed ID: 24172093
[TBL] [Abstract][Full Text] [Related]
57. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.
Xue Z; Zhu X; Teng Y
Med Sci Monit; 2016 Sep; 22():3186-90. PubMed ID: 27604213
[TBL] [Abstract][Full Text] [Related]
58. An extended APOBEC3A mutation signature in cancer.
Langenbucher A; Bowen D; Sakhtemani R; Bournique E; Wise JF; Zou L; Bhagwat AS; Buisson R; Lawrence MS
Nat Commun; 2021 Mar; 12(1):1602. PubMed ID: 33707442
[TBL] [Abstract][Full Text] [Related]
59. Estrogen receptor polymorphisms and the risk of endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
[TBL] [Abstract][Full Text] [Related]
60. APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.
Cescon DW; Haibe-Kains B; Mak TW
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2841-6. PubMed ID: 25730878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
